FDMT: 4D Molecular Therapeutics, Inc.
Performance
FDMT +18.86%
Watchlist
Select an item
Summary
FDMT at a glance
FDMT returned +18.86% over the past year and -12.74% a year over five years. Its worst drop in that year was -38.34%, smaller than 40% of stocks on Redstone, and its Sharpe ratio of 0.56 beats 54% of stocks on Redstone. It pays no dividends.
Current Drawdown
-25.54%
Rolling Volatility
89.30%
Actions
Metrics
Risk Indicators
Alpha25.32%
Beta1.83x
Sharpe0.56
Sortino0.81
Omega1.10
Calmar0.49
Martin2.11
Profile
About FDMT
4D Molecular Therapeutics Inc is biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients.
- Sector
- Health Care
- Industry
- Biological Products, (no Diagnostic Substances)
- Market cap
- $689M
- Listed
- Dec 2020
- Employees
- 196
- Headquarters
- Emeryville, CA
- Website
- 4dmoleculartherapeutics.com
Comparisons